Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Emily R Hankosky

9PUBLICATIONS
12CO-AUTHORS
Behavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Disease surveillanceOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Sep 29, 2025
Tirzepatide and the 10-year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three-year SURMOUNT-1 trial.

Emily R Hankosky, Jeremie Lebrec, Clare J Lee

|Jun 24, 2025
Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence.

Naveed Sattar, Luis-Emilio García-Pérez, Angel Rodríguez

|May 05, 2025
Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison.

Emily R Hankosky, Xuanyao He, Raleigh Malik

|Mar 14, 2025
Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® database.

Theresa Hunter Gibble, Chanadda Chinthammit, Jennifer M Ward

|Feb 25, 2025
Real-world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database.

Emily R Hankosky, Chanadda Chinthammit, Alexandra Meeks

|Nov 06, 2023
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis.

Emily R Hankosky, Hui Wang, Lisa M Neff

Pageof 2

Frequent Collaborators

2 joint publications

W Timothy Garvey

2 joint publications

Theresa Hunter Gibble

1 joint publications

Ágnes Benedict

1 joint publications

Kinga Marczell

1 joint publications

Jieling Chen

1 joint publications

J Jaime Caro

1 joint publications

Jay P Bae

1 joint publications

Brian D Benneyworth

1 joint publications

Naveed Sattar

1 joint publications

Luis-Emilio García-Pérez

Frequent Collaborators

2 joint publications

W Timothy Garvey

2 joint publications

Theresa Hunter Gibble

1 joint publications

Ágnes Benedict

1 joint publications

Kinga Marczell

Top Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on : May 30, 2025

906
Fixation and Operational Method for Abdominal Massage in T2DM Mice
06:00

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on : Mar 07, 2025

163
See more related videos

Top Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on : May 30, 2025

906
Fixation and Operational Method for Abdominal Massage in T2DM Mice
06:00

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on : Mar 07, 2025

163
See more related videos